Company Profile
SELLAS Life Sciences Group, Inc. Stock Price, News & Analysis
- Ticker:
- SLS
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, SELLAS Life Sciences Group is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
9.07 USD (+6.33%)
Close
Last updated: June 23, 2026 at 00:00
1.78B USD
Market cap
Why the stock is moving
SLS is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, SELLAS Life Sciences Group is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
SELLAS Life Sciences Group follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, SELLAS Life Sciences Group sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
SELLAS Life Sciences to Participate in Upcoming Investor Conferences
Source: SELLAS Life Sciences Group, Inc.
- 02
SELLAS Life Sciences Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: SELLAS Life Sciences Group, Inc.
- 03
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
Source: SELLAS Life Sciences Group, Inc.
- 04
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $31 Million in Gross Proceeds
Source: SELLAS Life Sciences Group, Inc.
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of SELLAS Life Sciences Group, Inc. (SLS)?
SELLAS Life Sciences Group, Inc. (SLS) most recently closed at 9.07 USD, a +6.33% move versus the previous session.
What is the market cap of SELLAS Life Sciences Group, Inc. (SLS)?
SELLAS Life Sciences Group, Inc. currently has a market capitalization of 1.78B USD on BioPharmSignal.
What does SELLAS Life Sciences Group, Inc. do?
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is SLS stock listed?
SELLAS Life Sciences Group, Inc. (SLS) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, SELLAS Life Sciences Group is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Life?
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is SELLAS Life Sciences Group, Inc. targeting with Life?
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Sciences?
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Group?
SELLAS Life Sciences Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.